Cambridge website for Synthetic Biology resourcesWith their provenance as an excellent source of pharmaceutical, neutraceutical and health promoting chemistries, plant natural products are an attractive target for biotechnological development for industrialization
(Re-)constructing and Re-programming Life This conference will provide an in-depth discussion forum among practitioners of the various fields underlying Synthetic Biology. It aims to pin-point the challenges,
Algae Innovation Center (AIC) Lolland commenced in 2010 as a project between Green Center, Roskilde University and Aalborg University with the aim of identifying and researching the potentials of using
The conference will focus on frontiers in biological design, synthetic biology and processing, bringing together the top academic, industrial and governmental researchers from both the East and the West. Specific
A hands-on Summer Course of advanced Genetic Engineering of Bacteria at the onset of the SynBio era.
GCAT-alog is freezer management software, optimized for use by synthetic biologists. GCAT-alog is freely available to use though no support other than the user manual is available.The tools can be accessed
This week-long summer school provides advanced training in history of the life sciences, a lively international field that offers a long-term perspective on some of the most significant ideas, practices
The BioBricks Foundation is pleased to announce The BioBricks Foundation Synthetic Biology 6.0 Conference (SB6.0), which will take place on July 9-11, 2013 at Imperial College, London, UK. This meeting
SynBioBeta is a forum to bring together synthetic biology startups as well as other stakeholders in the ecosystem. This evening event will be held during the BioBricks Foundation SB6.0 Conference. The
2nd International Synthetic Yeast Genome Consortium Meeting held in the UK at Imperial College London - bringing those around the world involved in the Sc2.0 project together to discuss progress and opportunities.
The flavors and fragrance (F&F) market seem to be benefiting from renewable chemicals developments from players such as Amyris, Allylix and Blue Marble Biomaterials...and chemical firms also supplying the F&F market are taking notice.
BASF announced on Monday that its venture capital business has invested $13.5m in Allylix, which BASF said allows them to leverage their aroma chemicals, nutrition and cosmetic chemicals competency. BASF is one of the biggest global producer of aroma chemicals by the way.
According to a study released last year by US accounting firm Marcum LLP and the Samuel Curtis Johnson Graduate School of Management at Cornell University, the market for aroma chemicals and essential oils are [either] both a rapidly expanding market segment [or] and a highly profitable product segment.
"The highest growth companies in the study, those that experienced over 6% growth year-over-year, generated 20% of their overall revenue from the sale of aroma chemical and essential oils while "low-growth" companies (those with 1-2% growth year-over-year) generated half as much of their revenue from this product segment."
Meanwhile, US market research firm Freedonia reported that the US market for F&F is forecast to rise 3%/year to $5.5bn in 2014. Among the major product segments, essential oils and natural extracts are projected to achieve the most rapid gains.
|
US FLAVORS & FRAGRANCES DEMAND
(million dollars)
|
|||||
|
% Annual Growth
|
|||||
|
2004
|
2009
|
2014
|
2004-2009
|
2009-2014
|
|
|
Flavor & Fragrance Demand
|
3910
|
4750
|
5500
|
4.0
|
3.0
|
|
Food
|
1436
|
1740
|
1990
|
3.9
|
2.7
|
|
Cosmetics & Toiletries
|
980
|
1270
|
1500
|
5.3
|
3.4
|
|
Cleaning Products
|
500
|
570
|
650
|
2.7
|
2.7
|
|
Environmental Fragrance Goods
|
397
|
470
|
560
|
3.4
|
3.6
|
|
Beverages
|
364
|
430
|
500
|
3.4
|
3.1
|
|
Other
|
233
|
270
|
300
|
3.0
|
2.1
|
Back to Allylix, the company said it will soon launch its rare and highly valuable terpene that is structurally related to beta-vetivone, one of the key component of vetiver oil - an essential oil. Beta-vetivone has never been commercialized because it cannot be produced synthetically in a cost-effective process, according to Allylix.
Trademarked Epivone, Allylix' product is expected to gain annual revenue between $20m and $200m based on revenues for similar terpene molecules used in fragrance applications.
Allylix expects to start production of Epivone in commercial quantities in the third quarter 2012 in applications such as cologne, hair care and personal care fragrance.
(Via ICIS Green Chemicals.)